3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Lung Neoplasms
4
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
3
Pituitary Neoplasms
2
Liver Neoplasms
2
Carcinoma, Neuroendocrine
2
Adrenal Gland Neoplasms
2
Thyroid Carcinoma, Anaplastic
1
Paraganglioma
1
Neurofibroma
1
Neuroendocrine Tumors
1
Neurilemmoma
1
Meningioma
1
Hypopituitarism
1
Growth Hormone-Secreting Pituitary Adenoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Colorectal Neoplasms
1
Chordoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Bone Neoplasms
1
Arteriovenous Malformations
1
Anal Canal Carcinoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Acromegaly
1
Interventions
pasireotide
5
lanreotide
3
Octreotide
3
Cabergoline
2
pegvisomant
1
Transcranial Magnetic Stimulation
1
Tissue Banks
1
Surgical Procedures, Operative
1
Solutions
1
Radiosurgery
1
Observation
1
Magnetic Resonance Spectroscopy
1
Injections
1
Dosage Forms
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acromegaly
×
Radiosurgery
×
Endocrine
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled